Pamiteplase

N/A

Report date: 2022/05/18 13:46:24

Base Information

Drug NamePamiteplase

Drug Alias Name重组组织纤溶酶原激活物（Astellas）帕米普酶SolinaseYM-866YM-22866

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionPlasminogen stimulants

TargetsPlasminogen

Therapy Area/IndicationsMyocardial Infarction

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsMyocardial Infarction

Inactive IndicationsN/A

ATC CodeB01AD